{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:34:05Z","timestamp":1790004845372,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jgaronline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jgar.2017.03.012","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T14:02:58Z","timestamp":1498831378000},"page":"70-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"special_numbering":"C","title":["Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus"],"prefix":"10.1016","volume":"10","author":[{"given":"Elaine Wang Ling","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2246-5450","authenticated-orcid":false,"given":"Zong Yang","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iswara","family":"Raja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5535-0732","authenticated-orcid":false,"given":"Jeremy Kean Yi","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.jgar.2017.03.012_bib0005","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1086\/519471","article-title":"Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections","volume":"45","author":"Micek","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2017.03.012_bib0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tibtech.2012.12.006","article-title":"Combination approaches to combat multidrug-resistant bacteria","volume":"31","author":"Worthington","year":"2013","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.jgar.2017.03.012_bib0015","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.chembiol.2014.02.009","article-title":"DNA replication is the target for the antibacterial effects of nonsteroidal anti-inflammatory drugs","volume":"21","author":"Yin","year":"2014","journal-title":"Chem Biol"},{"key":"10.1016\/j.jgar.2017.03.012_bib0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2334-14-47","article-title":"Aspirin enhances opsonophagocytosis and is associated to a lower risk for Klebsiella pneumoniae invasive syndrome","volume":"14","author":"Lee","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2017.03.012_bib0025","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/gut.52.4.490","article-title":"Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents","volume":"52","author":"Wang","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jgar.2017.03.012_bib0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejps.2015.02.011","article-title":"Antimicrobial activity of ibuprofen. New perspectives on an \u2018old\u2019 non-antibiotic drug","volume":"71","author":"Obad","year":"2015","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jgar.2017.03.012_bib0035","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s10096-009-0739-z","article-title":"The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug","volume":"28","author":"Mazumdar","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2017.03.012_bib0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/AAC.00735-10","article-title":"Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor","volume":"55","author":"Kalle","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2017.03.012_bib0045","series-title":"Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2014"},{"key":"10.1016\/j.jgar.2017.03.012_bib0050","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/AAC.00999-09","volume":"54","author":"Meletiadis","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2017.03.012_bib0055","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bios.2015.07.015","article-title":"Employing carbon dots modified with vancomycin for assaying Gram-positive bacteria like Staphylococcus aureus","volume":"74","author":"Zhong","year":"2015","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.jgar.2017.03.012_bib0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3121\/cmr.2007.698","article-title":"An evidence-based update on nonsteroidal anti-inflammatory drugs","volume":"5","author":"Ong","year":"2007","journal-title":"Clin Med Res"},{"key":"10.1016\/j.jgar.2017.03.012_bib0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/0974-777X.62880","article-title":"In vitro antibacterial activity of ibuprofen and acetaminophen","volume":"2","author":"Al-Janabi","year":"2010","journal-title":"\u200eJ Glob Infect Dis"},{"key":"10.1016\/j.jgar.2017.03.012_bib0070","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/j.ajkd.2006.12.014","article-title":"Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters","volume":"49","author":"Sedlacek","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jgar.2017.03.012_bib0075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1476-0711-10-30","article-title":"Alterations in the transcriptome and antibiotic susceptibility of Staphylococcus aureus grown in the presence of diclofenac","volume":"10","author":"Riordan","year":"2011","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jgar.2017.03.012_bib0080","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.35.19958-en","article-title":"Meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia in Tampere University Hospital: a case\u2013control study, Finland October 2002 to January 2010","volume":"16","author":"Rahikka","year":"2011","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jgar.2017.03.012_bib0085","first-page":"637","article-title":"In vitro susceptibility of chloramphenicol against methicillin-resistant Staphylococcus aureus","volume":"23","author":"Fayyaz","year":"2013","journal-title":"J Coll Phys Surg Pak"},{"key":"10.1016\/j.jgar.2017.03.012_bib0090","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1128\/AAC.05398-11","article-title":"Mechanisms of resistance to chloramphenicol in Pseudomonas putida KT2440","volume":"56","author":"Fern\u2136ndez","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2017.03.012_bib0095","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1021\/cb300413m","article-title":"Inhibition of WTA synthesis blocks the cooperative active of PBPs and sensitizes MRSA to \u03b2-lactams","volume":"8","author":"Farha","year":"2013","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.jgar.2017.03.012_bib0100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1128\/AAC.03502-14","article-title":"Synergistic interactions of vancomycin with different antibiotics against Escherichia coli: trimethoprim and nitrofurantoin display strong synergies with vancomycin against wild-type E. coli","volume":"59","author":"Zhou","year":"2015","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716517300784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716517300784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T03:44:58Z","timestamp":1659152698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716517300784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":20,"alternative-id":["S2213716517300784"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2017.03.012","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2017.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}